TherapeuticsMD OverviewTherapeuticsMD EBIT
EBIT (Earnings Before Interest and Taxes) analysis for TXMD.
Quarterly EBIT
-$723.00K
↓ 7.91% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$3.29M
↑ 5.7% YoY
Trailing 12 months ending Mar 31, 2026
TherapeuticsMD OverviewEBIT (Earnings Before Interest and Taxes) analysis for TXMD.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026